Pages that link to "Q78117337"
Jump to navigation
Jump to search
The following pages link to Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension (Q78117337):
Displaying 20 items.
- Structural Asymmetry in the Closed State of Mitochondrial Hsp90 (TRAP1) Supports a Two-Step ATP Hydrolysis Mechanism (Q27681454) (← links)
- Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava (Q28576001) (← links)
- Upregulation and intrarenal redistribution of heat shock proteins 90alpha and 90beta by low-sodium diet in the rat. (Q28581309) (← links)
- High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation (Q33782094) (← links)
- Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti-inflammatory effects and interacts with glucocorticoid receptor in vivo. (Q35042672) (← links)
- Nitric oxide and portal hypertension (Q35071865) (← links)
- Stability of the human Hsp90-p50Cdc37 chaperone complex against nucleotides and Hsp90 inhibitors, and the influence of phosphorylation by casein kinase 2 (Q35546665) (← links)
- Endothelial nitric oxide (NO) and its pathophysiologic regulation (Q36992714) (← links)
- Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction (Q37274252) (← links)
- Physiopathology of splanchnic vasodilation in portal hypertension (Q37821307) (← links)
- Conformational dynamics of the molecular chaperone Hsp90 (Q37854116) (← links)
- Current concepts on the role of nitric oxide in portal hypertension (Q38095931) (← links)
- New cellular and molecular targets for the treatment of portal hypertension (Q38383418) (← links)
- Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands. (Q38842676) (← links)
- Molecular Dynamics Simulations Reveal the Mechanisms of Allosteric Activation of Hsp90 by Designed Ligands (Q39768761) (← links)
- Murine study of portal hypertension associated endothelin-1 hypo-response (Q39923460) (← links)
- Role of HSP-90 for increased nNOS-mediated vasodilation in mesenteric arteries in portal hypertension (Q40094604) (← links)
- Early changes in vasoreactivity after simulated microgravity are due to an upregulation of the endothelium-dependent nitric oxide/cGMP pathway (Q43050296) (← links)
- Heat shock protein 90 and tyrosine kinase regulate eNOS NO· generation but not NO· bioactivity (Q44612929) (← links)
- Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats. (Q49362450) (← links)